For this purpose, the presence of TLR9 was analyzed in two populations of immune system cells: monocytes and DCs (myeloid and plasmacytoid DCss) and a quantitative analysis of the presence of the tested receptor in the serum of patients diagnosed with IgAN and MPGN was undertaken. The gene discussed is TLR9; the disease is primary membranoproliferative glomerulonephritis.